The federal government needs to support an inclusive engineering biology ecosystem that leverages Canadian-grown capacities across industry, academia and government, Bettina Hamelin, president and CEO of Ontario Genomics, says in an editorial. Canada needs a comprehensive and aligned roadmap for a public-private partnership and investment strategy to benefit from the increasing opportunities in this emerging sector, she says.
Organization: AbCellera Biologics
The Short Report – Dec 16, 2020: Canada signs historic space treaty, robotic warehouse tech gets a boost, and more
Ingrid Waldron and HealthCareCAN receive top Research Canada advocacy awards, AbCellera’s IPO nearly triples in value on first day of trading, Diversity Institute’s report on the Canadian labour market during the pandemic is out, and an international AI hub specializing in pharmaceutical R&D opens in Montreal.
The Short Report, May 6, 2020: AbCellera receives $175.6M for COVID-19 therapies; Canada contributes $850 million to global pandemic response; new “super angel” fund launches; and more
Vancouver-based AbCellera Biologics will receive up to $175.6 million from the federal Strategic Innovation Fund to fast-track antibody therapies against COVID-19. The funding will also go to build a first-of-its-kind antibody manufacturing facility over the next four years to help Canada respond to future pandemics. AbCellera has partnered with global biopharmaceutical company Eli Lilly to…
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...